Biodesix, Inc.
BDSX
$0.4442
$0.02044.81%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 20.02M | 17.96M | 20.43M | 18.15M | 17.93M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.02M | 17.96M | 20.43M | 18.15M | 17.93M |
| Cost of Revenue | 4.03M | 3.70M | 4.34M | 4.18M | 3.88M |
| Gross Profit | 15.99M | 14.26M | 16.09M | 13.97M | 14.05M |
| SG&A Expenses | 22.41M | 20.45M | 20.22M | 20.02M | 19.66M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 29.71M | 27.02M | 26.98M | 26.74M | 26.10M |
| Operating Income | -9.69M | -9.06M | -6.55M | -8.59M | -8.17M |
| Income Before Tax | -11.47M | -11.10M | -8.25M | -10.26M | -10.81M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.47M | -11.10M | -8.25M | -10.26M | -10.81M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.47M | -11.10M | -8.25M | -10.26M | -10.81M |
| EBIT | -9.69M | -9.06M | -6.55M | -8.59M | -8.17M |
| EBITDA | -8.26M | -7.62M | -5.10M | -7.10M | -6.76M |
| EPS Basic | -0.08 | -0.08 | -0.06 | -0.07 | -0.09 |
| Normalized Basic EPS | -0.05 | -0.05 | -0.03 | -0.04 | -0.05 |
| EPS Diluted | -0.08 | -0.08 | -0.06 | -0.07 | -0.09 |
| Normalized Diluted EPS | -0.05 | -0.05 | -0.03 | -0.04 | -0.05 |
| Average Basic Shares Outstanding | 146.66M | 146.55M | 146.60M | 146.30M | 127.17M |
| Average Diluted Shares Outstanding | 146.66M | 146.55M | 146.60M | 146.30M | 127.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |